N. Arvind Dasari, MD, is a medical oncologist at the MD Anderson Cancer Center in Houston, Texas. Since joining MD Anderson in 2011, Dr. Dasari’s clinical focus has been on neuroendocrine cancer and he currently serves as Co-Chair of the MD Anderson multidisciplinary neuroendocrine tumor board.
Dr. Dasari’s research interests include clinical, translational and outcomes work in gastrointestinal cancers with a particular emphasis on neuroendocrine tumors. He serves as the principal investigator of several clinical trials and research projects on neuroendocrine tumors. He is currently a member of the NCI Task Force for Neuroendocrine Tumors and also chairs the NANETS’ Continuing Education Committee.